Synthesis and antiradical activity of novel copper(II) complexes of long chain reduced Schiff base ligands
- 141 Downloads
Oxidative stress is the cause of many diseases and at the heart of it is the overproduction of reactive oxygen species (ROS). There are several protective enzymes, e.g., superoxide dismutases (SOD), able to decrease the level of ROS in the cell; however, a therapeutic use of these enzymes is problematic. Small molecule compounds and complexes able to scavenge free radicals such as superoxide anion radicals could be used instead. These compounds are often called SOD-mimics and various researches are interested in synthesis and study of these compounds. In our study, a series of Cu(II) complexes were synthesized, containing reduced Schiff base ligands prepared from salicylaldehyde and amino acids with longer chain length (5-aminopentanoic acid, 6-aminohexanoic acid, 8-aminooctanoic acid, 11-aminoundecanoic acid, and 12-aminododecanoic acid). Complexes prepared from these ligands are novel and were prepared using three different methods. An assay based on the ability to inhibit reduction of iodonitrotetrazolium dye by superoxide anion radicals was used to determine antiradical activity of the prepared complex. Most of the prepared complexes proved to be good antiradical agents compared to cystamine and the copper(II) complex with Schiff base type ligand N-salicylidene-β-alanine. The best IC50 values of the radical transfer of the prepared compounds were two complexes of N-(2-hydroxybenzyl)-11-aminoundecanoic acid: 97.0 ± 1.9 and 45.1 ± 0.5 μM.
KeywordsCoordination chemistry Crystal structure Amino acids Ligands Reduced Schiff bases Antiradical activity
This work was supported by the Slovak Research and Development Agency under Contract no. APVV-0516-12 and no. APVV-15-0079 and Scientific Grant Agency of the Slovak Republic VEGA (Project no. 1/0871/16 and 1/0346/16).
- 12.Tozokumi S (1996) Free Radic Biol Med 34:93Google Scholar
- 13.Noguchi S (2002) Free Radic Biol Med 1588:159Google Scholar
- 14.Halliwell B (1992) J Lab Clin Med 119:598Google Scholar
- 20.Ilkevycha NS, Schroeder G, Rybachenkoa VI, Chotiya KY, Makarova RA (2012) Spectrochim Acta A 86:821Google Scholar
- 39.Lurie EY, Kaplun AP, Kulakov VN, Shvets VI (1995) Russ J Bioorg Chem 21:264Google Scholar
- 41.Lintnerová L, Valentová J, Devínsky F (2016) Stud UBB Chem 61:85Google Scholar
- 43.Kudryashova V, Dikovskaya KI, Kalnins A, Kropivets LS, Freimanis J, Sakhartova OV, Turovskii IV (1988) Bioorg Khim 14:216Google Scholar
- 47.CrysAlisPro (2017) XRD products, version 171.38.43. Yarnton, Oxfordshire, United KingdomGoogle Scholar